Monday, April 20, 2015 9:50:34 PM
I have no doubt most of those labeled rapid progressors were in fact rapid progressors. But it's still possible one or two weren't. And 15.3 months mOS is certainly less than Linda was going around everywhere suggesting the "sickest of the sick" were doing. All that came out of her mouth was "18 months in the sickest of the sick, who usually die in 7-10 months." She never clarified. Sure, if you happened to read the fine print of the slide you'd have seen "actual or suspected rapid progressors," and if you further had the wherewithal to figure out you were being tricked and knew what a psPD even was you'd at least know what she was saying wasn't honest. But please, don't tell me she wasn't lying. I know what a lie is.
I also know you and flipper are really impressed with these patients having had 50% growth of their lesions after 5 months, but it's just not that special to an ePD. These are not "super rapids" or whatever you want to call them. They are quickly progressing ePD who usually die from 3-15 months historically. It's a sad, sick disease. If anything this new info should make you more suspicious of how to classify the "indeterminates." But with so much confirmation bias how could you?
You stated the criteria correctly but omitted when a patient is scanned for that criteria. The fact is after 2 months either those apparent lesions grew or stayed the same or even regressed (just not more than 25%) for those labeled "indeterminates." Well, how many regressed or were stable at 2 months post baseline scan? Most of them? Who knows! These could easily all be psPD. Every single one labeled "indeterminate." If they scanned again at 6 months etc., they would have more conclusive data. They just didn't. Nothing nefarious, they were compassionate use patients after all.
So, not really sure what point you're trying to make or thought you just made. Probably all or almost all of those labeled "rapid progressors" are ePD. Probably most if not nearly all of those labeled "indeterminates" are psPD. And because they did not take additional scans we'll never know.
These information arm data are simply unsubstantiated without a concurrent control group. It doesn't matter if the ePD mOS is 20 months, neither the market nor the greater health community will credit DCVax-L with the ability to procure a survival advantage unless such data comes from a randomized trial.
Aren't you all getting tired of my repeating the same rudimentary matters? Why not just learn it already instead of fighting against it constantly. Accept the truth.
I'd offer you advice, but I just don't care about your money, unless you give me money to care about your money. I might even be tricking you with the above post...
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM